MX2013007191A - Metodos y composiciones para prevenir y tratar la osteoartritis. - Google Patents

Metodos y composiciones para prevenir y tratar la osteoartritis.

Info

Publication number
MX2013007191A
MX2013007191A MX2013007191A MX2013007191A MX2013007191A MX 2013007191 A MX2013007191 A MX 2013007191A MX 2013007191 A MX2013007191 A MX 2013007191A MX 2013007191 A MX2013007191 A MX 2013007191A MX 2013007191 A MX2013007191 A MX 2013007191A
Authority
MX
Mexico
Prior art keywords
preventing
methods
compositions
treating osteoarthritis
treating
Prior art date
Application number
MX2013007191A
Other languages
English (en)
Spanish (es)
Inventor
Rondo Paul Middleton
Mark Kenneth Waldron
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013007191A publication Critical patent/MX2013007191A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2013007191A 2010-12-21 2011-12-15 Metodos y composiciones para prevenir y tratar la osteoartritis. MX2013007191A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061459902P 2010-12-21 2010-12-21
PCT/US2011/065173 WO2012087745A1 (en) 2010-12-21 2011-12-15 Methods and compositions for preventing and treating osteoarthritis

Publications (1)

Publication Number Publication Date
MX2013007191A true MX2013007191A (es) 2013-07-12

Family

ID=46314373

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007191A MX2013007191A (es) 2010-12-21 2011-12-15 Metodos y composiciones para prevenir y tratar la osteoartritis.

Country Status (11)

Country Link
US (1) US20140205569A1 (enExample)
EP (1) EP2654744A4 (enExample)
JP (1) JP2014505679A (enExample)
CN (1) CN103384521A (enExample)
AU (1) AU2011349718B2 (enExample)
BR (1) BR112013018453A2 (enExample)
CA (1) CA2822263A1 (enExample)
MX (1) MX2013007191A (enExample)
RU (1) RU2013133998A (enExample)
WO (1) WO2012087745A1 (enExample)
ZA (1) ZA201305497B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
WO2014022816A2 (en) * 2012-08-03 2014-02-06 Dignity Sciences Limited Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
WO2015185698A1 (en) 2014-06-04 2015-12-10 Dignity Sciences Limited Pharmaceutical compositions comprising dgla and use of same
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
US6765020B2 (en) * 1995-08-07 2004-07-20 Suntory Limited Drugs for prevention and treatment of diseases caused by abnormalities in cartilage tissues
GB9622636D0 (en) * 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
JP4343477B2 (ja) * 2000-05-25 2009-10-14 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ペットフード用新規プロバイオチックス
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
AU2004266601B2 (en) * 2003-08-11 2011-03-24 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for the treatment of canine ostheoarthritis
ES2998457T3 (en) * 2003-11-21 2025-02-20 Nestle Sa Food composition comprising glucosamine
AU2005259386B2 (en) * 2004-07-01 2011-11-03 Société des Produits Nestlé S.A. Canine osteoarthritis diet formulation
EP1852114B1 (en) * 2005-02-14 2019-09-18 Suntory Holdings Limited Composition containing dihomo-y-linolenic acid (dgla) as active ingredient
CN101460185A (zh) * 2006-04-03 2009-06-17 雀巢产品技术援助有限公司 用于促进骨生长和维持骨健康的营养组合物及与其有关的方法

Also Published As

Publication number Publication date
EP2654744A4 (en) 2014-07-02
AU2011349718A1 (en) 2013-07-04
RU2013133998A (ru) 2015-01-27
US20140205569A1 (en) 2014-07-24
EP2654744A1 (en) 2013-10-30
CN103384521A (zh) 2013-11-06
AU2011349718B2 (en) 2017-02-09
BR112013018453A2 (pt) 2018-05-22
JP2014505679A (ja) 2014-03-06
WO2012087745A1 (en) 2012-06-28
CA2822263A1 (en) 2012-06-28
ZA201305497B (en) 2015-01-28

Similar Documents

Publication Publication Date Title
IN2012DN02624A (enExample)
EA200900211A1 (ru) Замещенные производные имидазолона, их получение и применение
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
HRP20160598T1 (hr) Bakterijski sastavi za prevenciju i liječenje degenerativne bolesti
MX351670B (es) Bacteria bacillus para uso en tratar y prevenir infecciones en animales acuaticos.
PH12013500084A1 (en) Ip receptor agonist heterocyclic compounds
JO3313B1 (ar) التراكيب والطرق لزيادة نمو العضلة
MX339201B (es) Compuestos de sulfonamida y métodos para elaborarlos y usarlos.
WO2008016811A3 (en) Aminopiperidines and realted compounds
MX343135B (es) Compuestos de tipo fumagilol y métodos de realización y uso de los mismos.
PH12013500145B1 (en) Agonists of gpr40
PH12013502261A1 (en) Partially saturated tricyclic compounds and methods of making and using same
PH12012501740A1 (en) Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
MX2012006430A (es) Preparaciones de combinacion que comprenden un antagonista de citocina y un corticosteroide.
MX348898B (es) Métodos y composiciones para tratar, reducir, o prevenir el deterioro del sistema visual de los animales.
EA201592086A1 (ru) Жирная кислота таллового масла для использования в лечении и кормовые добавки и композиции для животных
EA201490032A1 (ru) Лиофилизированные препараты fgf-18
GB2483419A (en) Formulations for the treatment of deep tissue pain
IN2014CN04773A (enExample)
MX2013007191A (es) Metodos y composiciones para prevenir y tratar la osteoartritis.
MX357166B (es) Anticuerpos que se unen a notum pectinacetilesterasa.
EP4302825A3 (en) Pharmaceutical compositions for treatment of inappetence
IN2012DN03187A (enExample)
GB201009271D0 (en) Compositions
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.